Dr. Paiva is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5050 NE Hoyt St
Ste 540
Portland, OR 97213Phone+1 503-215-6600
Education & Training
- Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterResidency, Internal Medicine, 2020 - 2023
- Eastern Washington UniversityMPH, Public Health, 2017 - 2020
- Pacific Northwest University of Health Sciences College of Osteopathic MedicineClass of 2020
- University of VermontBS, Microbiology, 2009 - 2013
Certifications & Licensure
- OR State License 2022 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 32 citationsTargeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cellsScott R Best, Taylor Hashiguchi, Adam Kittai, Nur Bruss, Cody Paiva
Blood Advances. 2019-01-08 - 44 citationsTargeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.Cody Paiva, J C Godbersen, Allison Berger, Jennifer R. Brown, Alexey V. Danilov
Cell Death & Disease. 2015-07-09 - 12 citationsPevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis.Cody Paiva, J. Claire Godbersen, Taylor Rowland, Olga V. Danilova, Christopher George Danes
Oncotarget. 2017-02-03
Journal Articles
- . Targeting ubiquitin-activating enzyme induces ER stress mediated apoptosis in B-cell lymphoma cellsBest SR, Hashiguchi T, Kittai A, Briss N, Paiva CJ, Okada C, Liu T, Berger A, Danilov AV, Blood Advances, 1/2019
- Electronic Health Record Implementation: A Quality Assurance Assessment from a Free Clinic PerspectiveAsmussen A, Paiva CJ, Hepner E, Garibay A, McCarroll ML, J Comm Med Health Ed, 9/7/2017
- Pevonedistat, a Nedd8-activating Enzyme Inhibitor, Sensitizes Neoplastic B-Cells to Death Receptor-Mediated ApoptosisPaiva C, Godbersen JC, Rowland T, Danilova OV, Danes C, Berger A, Danilov AV, Oncotarget, 3/2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: